Last updated on November 2017

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease


Brief description of study

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Detailed Study Description

The study will involve an eighteen-week, double-blind, placebo-controlled parallel designed comparison between add-on topiramate and add-on placebo to stable treatment with amatadine in the treatment of PD patients who continue to have dyskinesia on amantadine.

Clinical Study Identifier: TX3550

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Claudia Rocha

University of South Florida - USF Health Byrd Alzheimer's Institute
Tampa, FL USA
  Connect »